Apolipoprotein E genotype and its effect on duration and severity of early and late onset Alzheimer's disease

Br J Psychiatry. 1995 Oct;167(4):533-6. doi: 10.1192/bjp.167.4.533.

Abstract

Background: The apolipoprotein E (ApoE) epsilon 4 allele is associated with an increased risk of senile and probably presenile Alzheimer's disease. It is not yet clear whether the epsilon 4 allele also influences the duration/rate of progress of illness and the severity of the dementia.

Method: We have retrospectively examined a series of ApoE genotyped presenile and senile autopsy cases of Alzheimer's disease (AD) for length of illness and severity of pathology.

Results: We find no evidence that ApoE genotype affects the rate of progress of AD, but the degree of pathology at death may be increased.

Conclusion: It appears that the rate of progress of AD as a whole is independent of the ApoE genotype.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Alleles
  • Alzheimer Disease / genetics*
  • Alzheimer Disease / pathology
  • Apolipoprotein E4
  • Apolipoproteins E / genetics*
  • Brain / pathology
  • Female
  • Gene Frequency
  • Genotype*
  • Humans
  • Male
  • Middle Aged
  • Prognosis

Substances

  • Apolipoprotein E4
  • Apolipoproteins E